Shiga University of Medical Science Wants to Correct Diovan Paper, Sent Data Found During Diovan Probe to US Journal

Vice President of Shiga University of Medical Science said that the university hopes to make partial corrections in its paper on the scandal-hit hypertension drug Diovan (valsartan) published in an American healthcare journal, instead of retracting it. Speaking at the...read more